Drug Shortage Report for MIDAZOLAM INJECTION
| Report ID | 250999 |
| Drug Identification Number | 02242904 |
| Brand name | MIDAZOLAM INJECTION |
| Common or Proper name | MIDAZOLAM INJECTION |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | MIDAZOLAM |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 5mL |
| ATC code | N05CD |
| ATC description | HYPNOTICS AND SEDATIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-03-01 |
| Actual start date | |
| Estimated end date | 2025-03-31 |
| Actual end date | 2025-04-03 |
| Shortage status | Resolved |
| Updated date | 2025-04-04 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to production delays, we will be encountering a supply interruption on our Midazolam Injection 1mg/mL MD Vial 5 mL effective March 1, 2025, until March 31, 2025. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2025-04-04 | English | Compare |
| v5 | 2025-04-03 | French | Compare |
| v4 | 2025-04-03 | English | Compare |
| v3 | 2025-03-02 | English | Compare |
| v2 | 2025-02-21 | French | Compare |
| v1 | 2025-02-21 | English | Compare |
Showing 1 to 6 of 6